This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
STEERLife, and Callidus ResearchLaboratories have forged a strategic partnership to accelerate drug development for global markets. The post STEERLife and Callidus ResearchLaboratories partner to accelerate drug development appeared first on Express Pharma.
Ebert, chair of Dana-Farber’s medical oncology department and a prize-winning researcher, will take over from Glimcher on Oct. In his current role Ebert oversees more than half of Dana-Farber’s 556 faculty members and more than 80 researchlaboratories. 1, the Boston institute said in a statement on Tuesday.
The company — which is a major supplier of non-human primates to corporate, government, and academic researchlaboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing. ( See page 42.)
Under a technology licensing agreement with Bhami ResearchLaboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.
The company — which is a major supplier of non-human primates to corporate, government, and academic researchlaboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.
The Simular Reaction Calorimeter will be installed in ICT Mumbais researchlaboratory and integrated into chemical synthesis workflows. The system will be utilised in the Institutes educational, mentoring, and research programmes to support the development of safe chemical processes.
In-vitro studies conducted at the British virology researchlaboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19.
. “The biopharmaceutical industry has only just started to harness the tremendous opportunity presented by emerging technological developments in AI and ML,” said Fiona Marshall, head of discovery, preclinical and translational medicine at Merck ResearchLaboratories.
Merck ResearchLaboratories chief medical officer, global clinical development head and senior vice-president Dr Eliav Barr said: “This long-term collaboration combining Merck’s expertise in immuno-oncology with Moderna’s pioneering mRNA technology has yielded a novel tailored vaccine approach.
“I look forward to working with the Prometheus team to establish a new paradigm of precision treatment for immune diseases,” commented Dr Dean Y Li, President of Merck ResearchLaboratories.
Merck ResearchLaboratories president Dr Dean Li said: “Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer. “We The latest deal complements and bolsters the oncology pipeline of Merck.
The facility will focus on developing next-generation molecules using generative AI platforms, particularly in the ophthalmic, ENT, Paediatrics and skincare segments ENTOD Pharmaceuticals has inaugurated its state-of-the-art Research & Development Centre in Navi Mumbai on Sunday, January 28th.
. “This approval demonstrates our progress in bringing Keytruda to patients with earlier stages of cancer, with the goal of helping more patients around the globe prevent disease recurrence,” said Scot Ebbinghaus, head of clinical research at Merck ResearchLaboratories.
This is our second acquisition in gene therapy, following the 2021 acquisition of Prevail Therapeutics,” added Dr Daniel Skovronsky, Lilly’s Chief Scientific and Medical Officer and President of Lilly ResearchLaboratories. “With Akouos, we are optimistic that we can make a difference for people with hearing loss.”
Pharmacists can work in a variety of settings, including hospitals, community pharmacies, researchlaboratories, and government agencies. Flexibility in work hours and settings Pharmacy offers a great deal of flexibility in terms of work hours and settings.
Li, President of Merck ResearchLaboratories. “We Lysine-specific demethylase 1 (LSD1). Evidence indicates that LSD1 (KDM1A) plays an important role in the maturation of blood cells in the bone marrow,” noted Dr Dean Y.
At the beginning of his career in 2004, Dr Hughes was responsible for early clinical research at Bristol Myers-Squibb Company and then at Schering-Plough Research Institute. Dr Hughes earned his MD and PhD at Yale School of Medicine.
Multiple flow chemistry platforms have been installed into a researchlaboratory at the site to allow the investigation of a wide range of chemical processes, including photolysis, electrochemistry and hydrogenations, as well. Announcement of the investment follows the appointment of Professor Ian R.
Co-principal investigator on the study, Dr Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging ResearchLaboratory at Duke University added: “It often takes tens of millions of dollars and many years to do a head-to-head comparison of drugs.”.
This approach developed in collaboration between an academic researchlaboratory and a pharmaceutical company is not just about lowering cholesterol—it’s about creating a new paradigm to design drugs that can prevent diseases by targeting proteins more cleverly.
Global biopharma companies and researchlaboratories recognize the value of investing in their workforce—training, upskilling, and certification—to unlock the full potential of employees and optimize available resources. The organization’s mission, “From insight to outcome,” underscores its commitment to delivering tangible results.
Dean Li, president of Merck ResearchLaboratories, told the meeting that cardiovascular disease is a big opportunity as it remains an epidemic, killing 35 million people during the pandemic while COVID-19 claimed the lives of 10 million.
Merck ResearchLaboratories president Dr Dean Li said: “The EyeBio acquisition further diversifies our late-stage pipeline with the addition of a promising candidate based on novel biology and genetics for the treatment of certain retinal diseases.
Process applications for special exemptions to import unregistered products from government institutions, the private sector, higher education institutions, and researchlaboratories. Monitor the progress of inspection activities involving pharmaceutical products, poisons, and chemicals controlled under applicable acts.
The centre will also be a hub for innovation, dedicating over half of its space to advanced researchlaboratories. A subsidiary of Bayer, the company aims to enhance its chemoproteomics screening capacity and further its clinical and preclinical programmes with this new facility.
The triad event is well-known to bring top international and home-grown machinery manufacturers, suppliers of analytical instruments and laboratory equipment, leading pharma companies, researchlaboratories, consultants, industry experts and key government officials under one roof to network and unlock business opportunities.
Merck ResearchLaboratories senior vice president for global clinical development and head of late-stage oncology Dr. Marjorie Green said: “In 2021, WELIREG became the first HIF-2α inhibitor therapy approved in the U.S. Furthermore, WELIREG showed an objective response rate (ORR) of 22% against 4% for everolimus.
The company noted that Merck gained more than 100 regulatory approvals during Perlmutter’s seven-year tenure as president of Merck ResearchLaboratories, before retiring last year.
Merck ResearchLaboratories global clinical development senior vice-president Dr Joerg Koglin said: “Despite advances in the treatment of PAH over the last two decades, there is still a significant need to improve outcomes for patients.
Merck ResearchLaboratories global clinical development vice-president Dr Elizabeth Rhee stated: “PREVYMIS has been an important addition to the care of high-risk adult CMV-seropositive patients who have received allogeneic stem cell transplants to help prevent CMV infection and disease.
Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck ResearchLaboratories said in a statement that the data marked the first time an anti-PD-1 therapy showed potential adjuvant treatment for patients with RCC.
Results showed that patients treated with Padcev along with KEYTRUDA achieved a confirmed ORR of 68%. 12% experienced a complete response and 55% a partial response.
The rights to the oRNA-LNP technology platform of Orna will be retained by the company, which will also progress various other fully owned programmes in oncology and genetic disease areas. In addition, Merck will make a $100m equity investment in Orna’s Series B funding round concluded recently.
Merck ResearchLaboratories president Dr Dean Li said: “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site. Merck will also make tiered royalty payments on net sales for any ADC product commercialised to Kelun-Biotech.
Merck ResearchLaboratories global clinical development head, senior vice-president and chief medical officer Dr Eliav Barr said: “Based on compelling data from our clinical trial programme, Keytruda has become an important treatment option in Japan and now has 23 approved uses across 13 different types of cancer.
Keytruda’s other indications remain unaffected, and Roy Baynes, head of global clinical development at Merck ResearchLaboratories emphasised that Keytruda remains “foundational” for treatment of certain patients with non-small cell lung cancer.
They have also created tissue research images at the IPU and other ICR researchlaboratories. Researchers at the unit are integrating digital pathology, tissue hybridisation and AI technologies to gain better understanding of major aspects of cancer pathology.
Dr Sam Engel, associate vice president, Merck clinical research, diabetes and endocrinology, Merck ResearchLaboratories, said: “Data from phase 2 studies has provided compelling clinical evidence that warrants further evaluation of efinopegdutide for the treatment of NASH.”.
Multiple reports suggest that researchlaboratories consume up to 10x more energy and 4x more water than office spaces, which can impact not only the efficiency but also the productivity of the laboratory. To combat the same, most pharma and life sciences companies have their own sustainability goals in motion.
. “Advances in ADC technologies are yielding a new generation of candidates designed to more precisely target and deliver potent anticancer agents to the tumour site,” said Dean Li, president of Merck ResearchLaboratories.
“Frequently diagnosed at an advanced stage, hepatocellular carcinoma has one of the highest mortality rates of solid cancers,” said Merck ResearchLaboratories’ clinical research head Scot Ebbinghaus. He said the company will “look forward to engaging with regulatory authorities as quickly as possible.”
Dr Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck ResearchLaboratories, said the data showing a 36% reduction in the risk of death “are compelling”.
Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, researchlaboratories and service companies have sprung up or settled in recent years. In mid-sized Charleston, connections and collaborations are a constant.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content